Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1089-1092

  Ichinohasama, Ryo ^a   Oji, Yusuke ^b   Yokoyama, Hisayuki ^a   Takeuchi, Kengo ^c   Fujiwara, Tohru ^a   Ishizawa, Kenichi ^a   Taniguchi, Osamu ^b   Tsuboi, Akihiro ^b   Oka, Yoshihiro ^b   Sugiyama, Haruo ^b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINYLMETHIONYLTHREONYLTRYPTOPHYLASPARAGINYLGLUTAMYLMETHIONYLASPARAGINYLLEUCINE; PEPTIDE ANTIBODY; UNCLASSIFIED DRUG; WT1 PROTEIN;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; WESTERN BLOTTING;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WT1 PROTEINS;

EID: 77953219241     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01522.x     Document Type: Article

References (22)

1. Oji Y, Miyoshi S, Maeda H. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 2002, 100:297-303.
2. Ueda T, Oji Y, Naka N. Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas. Cancer Sci 2003, 94:271-6.
3. Oji Y, Yamamoto H, Nomura M. Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci 2003, 94:712-7.
4. Oji Y, Yano M, Nakano Y. Overexpression of the Wilms' tumor gene in esophageal cancer. Anticancer Res 2004, 24:3103-8.
5. Oji Y, Suzuki T, Nakano Y. Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors. Cancer Sci 2004, 95:822-7.
6. Oji Y, Nakamori S, Fujikawa M. Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma. Cancer Sci 2004, 95:583-7.
7. Oka Y, Udaka K, Tsuboi A. Cancer immunotherapy targeting Wilms' tumor gene WT1 product. J Immunol 2000, 164:1873-80.
8. Oka Y, Tsuboi A, Elisseeva OA, Udaka K, Sugiyama H. WT1 as a novel target antigen for cancer immunotherapy. Curr Cancer Drug Targets 2002, 2:45-54.
9. Nakajima H, Kawasaki K, Oka Y. WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone. Cancer Immunol Immunother 2004, 53:617-24.
10. Oka Y, Tsuboi A, Taguchi T. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci U S A 2004, 101:13885-90.
11. Oka Y, Tsuboi A, Kawakami M. Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers. Curr Med Chem 2006, 13:2345-52.
12. Morita S, Oka Y, Tsuboi A. A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data. Jpn J Clin Oncol 2006, 36:231-6.
13. Izumoto S, Tsuboi A, Oka Y. Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme. J Neurosurg 2008, 108:963-71.
14. Foster MR, Johnson JE, Olson SJ, Allred DC. Immunohistochemical analysis of nuclear versus cytoplasmic staining of WT1 in malignant mesotheliomas and primary pulmonary adenocarcinomas. Arch Pathol Lab Med 2001, 125:1316-20.
15. Chen BF, Tzen CY, Liang DC, Liu HC, Huang YW, Fan CC. Immuno-histochemical expression of Wilms' tumor 1 protein in nephroblastoma. J Chin Med Assoc 2004, 67:506-10.
16. Waldstrøm M, Grove A. Immunohistochemical expression of Wilms tumor gene protein in different histologic subtypes of ovarian carcinomas. Arch Pathol Lab Med 2005, 129:85-8.
17. Wilsher M, Cheerala B. WT1 as a complementary marker of malignant melanoma: an immunohistochemical study of whole sections. Histopathology 2007, 51:605-10.
18. Kushitani K, Takeshima Y, Amatya VJ, Furonaka O, Sakatani A, Inai K. Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int 2007, 57:190-9.
19. Ellison DA, Parham DM, Bridge J, Beckwith JB. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: a potential source of confusion? A study of 30 cases from the National Wilms Tumor Study Pathology Center. Hum Pathol 2007, 38:205-11.
20. Oji Y, Kitamura Y, Kamino E. WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor. Int J Cancer 2009, 125:381-7.
21. Nakatsuka S, Oji Y, Horiuchi T. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 2006, 19:804-14.
22. Kerst G, Bergold N, Gieseke F. WT1 protein expression in childhood acute leukemia. Am J Hematol 2008, 83:382-6.